Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | CDC25A | P30304 | 6/20 | 0.37 |
| ▸ | CDC25B | P30305 | 6/20 | 0.37 |
| ▸ | CDC25C | P30307 | 5/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2315804 | 1.00 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL4629705 | 1.00 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL704205 | 0.98 | ACHE (0.34) | ACHEBACE1CDC25ACDC25BCDC25C | |
| Hexanoate SCHEMBL27802806 | 0.86 | SCD (0.51) | CDC25ACDC25BCDC25CGPR84 | |
| SCHEMBL9992284 | 0.81 | FNTA (0.37) | — | |
| SCHEMBL7054062 | 0.80 | CYP1A2 (0.34) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL9264130 | 0.76 | ACHE (0.40) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL8780203 | 0.76 | ACHE (0.40) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL14751591 | 0.75 | GPR84 (0.37) | ACHEBACE1CDC25ACDC25BCDC25C | |
| SCHEMBL11156027 | 0.74 | ACHE (0.37) | ACHEBACE1CDC25ACDC25BCDC25C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117187010-A | New use of nano enzyme capable of removing active oxygen | 四川轻化工大学 | 2023-12-08 | — | — | CN | claimed |
| EP-2167025-B1 | PRESERVATIVE-FREE COMPOSITIONS COMPRISING CINNAMIC OR ANISIC ACID AND A BENZALDEHYDE (DERIVATIVE) | GIVAUDAN SA (CH) | 2018-08-08 | — | — | EP | claimed |
| US-9084827-B2 | Biodegradable polyurethane/urea compositions | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2015-07-21 | — | — | US | claimed |
| US-20140099277-A1 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2014-04-10 | — | — | US | claimed |
| US-20130150964-A1 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | POLYNOVO BIOMATERIALS PTY LIMITED (AU) | 2013-06-13 | — | — | US | claimed |
| US-20100183692-A1 | COMPOSITIONS | GIVAUDAN SA (CH) | 2010-07-22 | — | — | US | claimed |
| US-20080118591-A1 | mixture contains perfume ingredients active against gramnegative bacteria; alcohols, aldehydes, ketones, imines, esters compound; low concentrations of Triclosan or other phenolic biocides; for disinfection, cleaning; liquid soaps for washing, shampoo; oral care products, mouth wash, tooth paste | GIVAUDAN SA (CH) | 2008-05-22 | — | — | US | claimed |
| US-20080021098-A1 | Antifungal Compositions | GIVAUDAN SA (CH) | 2008-01-24 | — | — | US | claimed |
| EP-1853214-A1 | BACTERICIDAL FORMULATIONS | Givaudan SA (CH) | 2007-11-14 | — | — | EP | claimed |
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | claimed |
| WO-2006053458-A1 | BACTERICIDAL FORMULATIONS | GIVAUDAN SA (CH) | 2006-05-26 | — | — | WO | claimed |
| WO-2005079573-A1 | ANTIFUNGAL COMPOSITIONS | GIVAUDAN SA (CH) | 2005-09-01 | — | — | WO | claimed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| CN-117187010-A | New use of nano enzyme capable of removing active oxygen | 四川轻化工大学 | 2023-12-08 | — | — | CN | disclosed |
| EP-4086329-A1 | PERFUME COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-108546592-B | Mixed spice of dark plum and raspberry, preparation method of mixed spice and application of mixed spice in cigarettes | 河南中烟工业有限责任公司 | 2022-02-25 | — | — | CN | disclosed |
| US-20040220356-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220377-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220373-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021098-A1 | Antifungal Compositions | ERG28, DPM1, SORD | ACHE 3864/4885BACE1 900/4885CDC25A 249/4885 |
| US-20100183692-A1 | COMPOSITIONS | NISCH, CUTA, C9 | ACHE 2051/4885BACE1 711/4885CDC25A 2905/4885 |
| US-20140099277-A1 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | PUF60, UMPS, COL2A1 | ACHE 4303/4885BACE1 4733/4885CDC25A 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.